Clinical Trial Update: A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing alendronate and raloxifene in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Raloxifene (raloxifene)
• alendronate (alendronate)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED